RT Journal Article
SR Electronic
T1 Irremediable psychiatric suffering in the context of physician assisted death: a Delphi-study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.19.21260430
DO 10.1101/2021.07.19.21260430
A1 Sisco M.P. van Veen
A1 Natalie Evans
A1 Andrea M. Ruissen
A1 Joris Vandenberghe
A1 Aartjan T.F. Beekman
A1 Guy A.M. Widdershoven
YR 2021
UL http://medrxiv.org/content/early/2021/07/22/2021.07.19.21260430.abstract
AB Background Patients with a psychiatric disorder (PPD) are eligible to request physician assisted death (PAD) in a small but growing number of jurisdictions, including the Netherlands and Belgium. For this request to be granted, most of these jurisdictions demand that the patient is competent in her request, and that the suffering experienced is unbearable and irremediable. Especially the criterion of irremediability is challenging to establish in patients with psychiatric disorders.Aims To establish what criteria Dutch and Belgian experts agree to be essential in characterising irremediable psychiatric suffering (IPS) in the context of PAD.Method A two round Delphi procedure among psychiatrists with relevant experience.Results Thirteen consensus-criteria were established: five diagnostic and eight treatment-related criteria. Diagnostically, the participants deem a narrative description and attention to contextual and systemic elements necessary. Also, a mandatory second opinion is required. The criteria concerning treatment show that extensive biopsychosocial treatment is needed, and the suffering must be present for several years. Finally, in the case of treatment refusal, the participants agree that there are limits to the number of diagnostic procedures or treatments a patient must undergo.Conclusions Consensus was found among a Dutch and Belgian expert group on essential criteria for establishing IPS in the context of PAD. These criteria can be used in clinical decision making and can inform future procedural demands and research.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://osf.io/qx5hy/ Funding StatementThe author(s) received no financial support for the research, authorship, and/or publication of this article.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval for this study was obtained in the form of a non-WMO declaration from the Medical Ethical Examination Board of Amsterdam UMC / VUmc under registration number D326.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data referred to in the manuscript is available through osf.io/qx5hy/ https://osf.io/qx5hy/